Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tivic Health Systems (TIVC) Cash from Financing Activities (2021 - 2025)

Historic Cash from Financing Activities for Tivic Health Systems (TIVC) over the last 5 years, with Q3 2025 value amounting to $4.3 million.

  • Tivic Health Systems' Cash from Financing Activities rose 450412.37% to $4.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.9 million, marking a year-over-year increase of 15028.54%. This contributed to the annual value of $4.3 million for FY2024, which is 4907.72% down from last year.
  • Latest data reveals that Tivic Health Systems reported Cash from Financing Activities of $4.3 million as of Q3 2025, which was up 450412.37% from $2.4 million recorded in Q2 2025.
  • In the past 5 years, Tivic Health Systems' Cash from Financing Activities ranged from a high of $14.9 million in Q4 2021 and a low of -$584000.0 during Q4 2022
  • Moreover, its 5-year median value for Cash from Financing Activities was $1.2 million (2024), whereas its average is $2.4 million.
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first crashed by 10392.29% in 2022, then skyrocketed by 762727.27% in 2024.
  • Quarter analysis of 5 years shows Tivic Health Systems' Cash from Financing Activities stood at $14.9 million in 2021, then tumbled by 103.92% to -$584000.0 in 2022, then surged by 850.17% to $4.4 million in 2023, then tumbled by 73.11% to $1.2 million in 2024, then soared by 262.65% to $4.3 million in 2025.
  • Its Cash from Financing Activities stands at $4.3 million for Q3 2025, versus $2.4 million for Q2 2025 and $82000.0 for Q1 2025.